Prudent Man Advisors LLC Buys 932 Shares of UnitedHealth Group Incorporated $UNH

Prudent Man Advisors LLC boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 34.2% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 3,659 shares of the healthcare conglomerate’s stock after purchasing an additional 932 shares during the period. Prudent Man Advisors LLC’s holdings in UnitedHealth Group were worth $1,141,000 as of its most recent filing with the SEC.

Several other hedge funds have also added to or reduced their stakes in the stock. Nabity Jensen Investment Management Inc raised its position in UnitedHealth Group by 0.9% in the first quarter. Nabity Jensen Investment Management Inc now owns 2,760 shares of the healthcare conglomerate’s stock worth $1,446,000 after acquiring an additional 24 shares during the period. Atlantic Edge Private Wealth Management LLC raised its position in UnitedHealth Group by 8.9% in the first quarter. Atlantic Edge Private Wealth Management LLC now owns 305 shares of the healthcare conglomerate’s stock worth $160,000 after acquiring an additional 25 shares during the period. HHM Wealth Advisors LLC raised its position in shares of UnitedHealth Group by 0.9% in the first quarter. HHM Wealth Advisors LLC now owns 2,947 shares of the healthcare conglomerate’s stock valued at $1,544,000 after purchasing an additional 26 shares during the period. Brogan Financial Inc. raised its position in shares of UnitedHealth Group by 3.4% in the first quarter. Brogan Financial Inc. now owns 819 shares of the healthcare conglomerate’s stock valued at $429,000 after purchasing an additional 27 shares during the period. Finally, West Wealth Group LLC raised its position in shares of UnitedHealth Group by 3.2% in the first quarter. West Wealth Group LLC now owns 882 shares of the healthcare conglomerate’s stock valued at $462,000 after purchasing an additional 27 shares during the period. Institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the stock. Mizuho boosted their price target on shares of UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a research report on Thursday, October 9th. KeyCorp boosted their price target on shares of UnitedHealth Group from $350.00 to $400.00 and gave the company an “overweight” rating in a research report on Wednesday, October 8th. Zacks Research raised shares of UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research note on Monday, October 6th. Barclays boosted their price objective on shares of UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a research note on Thursday, October 9th. Finally, Oppenheimer reduced their price objective on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a research note on Wednesday, July 30th. Eighteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average target price of $385.13.

UnitedHealth Group Price Performance

UNH stock opened at $362.78 on Friday. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The stock has a market cap of $328.56 billion, a PE ratio of 15.72, a P/E/G ratio of 2.35 and a beta of 0.47. The firm has a 50 day simple moving average of $338.43 and a two-hundred day simple moving average of $337.48.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. During the same period in the prior year, the firm earned $6.80 EPS. UnitedHealth Group’s quarterly revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s payout ratio is currently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.